Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Other financing activities (2019 - 2023)

Historic Other financing activities for Eton Pharmaceuticals (ETON) over the last 4 years, with Q4 2023 value amounting to -$1000.0.

  • Eton Pharmaceuticals' Other financing activities changed N/A to -$1000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $180000.0, marking a year-over-year change of. This contributed to the annual value of $180000.0 for FY2023, which is N/A changed from last year.
  • Per Eton Pharmaceuticals' latest filing, its Other financing activities stood at -$1000.0 for Q4 2023.
  • Over the past 5 years, Eton Pharmaceuticals' Other financing activities peaked at $1.0 million during Q3 2021, and registered a low of -$1000.0 during Q4 2023.
  • Moreover, its 4-year median value for Other financing activities was $605000.0 (2019), whereas its average is $573214.3.
  • In the last 5 years, Eton Pharmaceuticals' Other financing activities surged by 579.71% in 2020 and then soared by 8438.36% in 2021.
  • Eton Pharmaceuticals' Other financing activities (Quarter) stood at $501000.0 in 2019, then soared by 54.29% to $773000.0 in 2020, then rose by 11.64% to $863000.0 in 2021, then crashed by 100.12% to -$1000.0 in 2023.
  • Its Other financing activities was -$1000.0 in Q4 2023, compared to $181000.0 in Q1 2023 and $863000.0 in Q4 2021.